Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|April 13, 2023
Choroidal Hyperreflective Nodules Detected by Infrared Reflectance Images Are a Diagnostic Criterion for Neurofibromatosis Type 1 Patients Excluding Those with High MyopiaMarta Orejudo de Rivas, Javier Mateo Gabás, Miguel Ángel Torralba Cabeza, et al.
Thorax|October 5, 2016
Role of acid sphingomyelinase and IL-6 as mediators of endotoxin-induced pulmonary vascular dysfunctionRachele Pandolfi, Bianca Barreira, Enrique Moreno, et al.
Frontiers in Immunology|February 14, 2022
SARS-CoV-2 Infection Triggers Auto-Immune Response in ARDSPablo Juanes-Velasco, Alicia Landeira-Viñuela, Marina L García-Vaquero, et al.
The Journal of Clinical Investigation|February 3, 2011
The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk regionRaquel Herrero, Osamu Kajikawa, Gustavo Matute-Bello, et al.
Life Science Alliance|July 18, 2023
Brain IGF-I regulates LTP, spatial memory, and sexual dimorphic behaviorRaquel Herrero-Labrador, Joaquín Fernández-Irigoyen, Rebeca Vecino, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|November 28, 2023
A role for astrocytic insulin-like growth factor I receptors in the response to ischemic insultKentaro Suda, Jaime Pignatelli, Laura Genis, et al.
International Journal of Molecular Sciences|August 12, 2023
The Proof-of-Concept of MBA121, a Tacrine-Ferulic Acid Hybrid, for Alzheimer's Disease TherapyEmelina R Rodríguez-Ruiz, Raquel Herrero-Labrador, Ana P Fernández-Fernández, et al.
Respiratory Research|June 9, 2026
Benchtop NMR as a clinical tool for acute respiratory illness: metabolic signatures associated with disease severityPilar Alonso-Moreno, Zuriñe Blasco-Iturri, Carolina Gotera Rivera, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|March 12, 2025
Preclinical evaluation of several polymeric micelles identifies Soluplus®-docetaxel as the most effective candidate in multiple glioblastoma modelsJúlia German-Cortés, Raquel Herrero, Natalia Torroglosa, et al.
Pageof 8